Publication:
New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study

Loading...
Thumbnail Image

Date

2021-01-01T00:00:00Z

Authors

Maccallini, Cristina
Gallorini, Marialucia
Sisto, Francesca
AKDEMİR, ATİLLA
Ammazzalorso, Alessandra
De Filippis, Barbara
Fantacuzzi, Marialuigia
Giampietro, Letizia
Carradori, Simone
Cataldi, Amelia

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Nonsteroidal aromatase inhibitors (NSAIs) are well-established drugs for the therapy of breast cancer. However, they display some serious side effects, and their efficacy can be compromised by the development of chemoresistance. Previously, we have reported different indazole-based carbamates and piperidine-sulphonamides as potent aromatase inhibitors. Starting from the most promising compounds, here we have synthesised new indazole and triazole derivatives and evaluated their biological activity as potential dual agents, targeting both the aromatase and the inducible nitric oxide synthase, being this last dysregulated in breast cancer. Furthermore, selected compounds were evaluated as antiproliferative and cytotoxic agents in the MCF-7 cell line. Moreover, considering the therapeutic diversity of azole-based compounds, all the synthesized compounds were also evaluated as antifungals on different Candida strains. A docking study, as well as molecular dynamics simulation, were carried out to shed light on the binding mode of the most interesting compound into the different target enzymes catalytic sites.

Description

Keywords

Aromatase, breast cancer, 14a-demethylase, azoles, inhibitors, iNOS

Citation

Page Views

0

File Downloads

12

Sustainable Development Goals